Nonshrinkable Thermosensitive Hydrogels Combined with Bispecific Anti-PSMA/CD3 T-Cell Engager for Effective Against Tumors in Mice Model
In conclusion, we developed relatively convenient injectable thermosensitive D<sub>2</sub>gel with a desirable gelation temperature window, which have the potential to be used for antibody drug delivery in several biomedical applications.
Authors
- Baole Wen (ORCID: https://orcid.org/0000-0003-2073-1508)
- Kai‐Hsiang Chuang (ORCID: https://orcid.org/0000-0002-8356-0657)
- Hong‐Yuan Hsu (ORCID: https://orcid.org/0000-0002-5720-4835)
- Yi-Jou Chen
- Ming‐Thau Sheu (ORCID: https://orcid.org/0000-0003-1995-8369)
- Po-Yu Chou (ORCID: https://orcid.org/0000-0002-0821-5837)
- Pu-Sheng Wei (ORCID: https://orcid.org/0009-0008-1595-2705)
- Michael Chen (ORCID: https://orcid.org/0000-0001-8899-9661)
- Hong-Liang Lin (ORCID: https://orcid.org/0000-0001-8661-7279)
- Tung‐Han Tsai
Institutions
- Kaohsiung Medical University (TW)
- Yuanpei University (TW)
- Taipei Medical University Hospital (TW)
- Genomics Research Center, Academia Sinica (TW)
- Taipei Medical University (TW)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2025-03-01
- DOI
- https://doi.org/10.2147/ijn.s496746
- Citations
- 3
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 1.79